Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

The worldwide psoriasis community celebrated a major achievement in February when the World Health Organization issued its comprehensive, 44-page “WHO Global Report on Psoriasis,” which details the global burden of the disease, and recommends ways to improve access to health care and address the disease’s social consequences. 

The report is a response to a 2014 resolution made by the World Health Assembly, an arm of the WHO, recognizing psoriasis as a serious, noncommunicable disease that deserves global attention.

The report “intends to empower policymakers with practical solutions to improve the health care and social inclusion of people living with psoriasis in their populations,” wrote Dr. Oleg Chestnov, WHO assistant director-general, noncommunicable diseases, and mental health, in the report’s foreword.

The report describes the disease’s numerous consequences, including significant comorbidities, stigmatization, and the often-debilitating effects on quality of life.

It also makes recommendations for what governments, policymakers, healthcare professionals, researchers, patients themselves, and society, in general, can do to improve access to care and quality of life.

Among the report’s key findings:

• The prevalence of psoriasis in countries ranges between 0.09% and 11.4%, making it a serious global problem.

• People with psoriasis suffer needlessly due to incorrect or delayed diagnosis, inadequate treatment options, and insufficient access to care.

Among the report’s recommendations:

• Governments and policymakers can support research and development of medicines for noncommunicable diseases, including psoriasis, that primarily affects low and middle-income countries. They can also provide access to medicines for all.

• Health systems must adopt a patient-centered approach to care, including other issues related to their health and well-being.

• Healthcare organizations must increase the skills and capacity of primary health care providers for psoriasis diagnosis, treatment, and management.

• Research is needed in many areas, including the etiology of the disease, therapies to prevent and manage symptoms, new and affordable treatments that can be available globally, the association between psoriasis and cardiovascular disorders, and more reliable outcomes.

The full WHO report is available at Report

WHO report bolsters Psoriasis Global Atlas project

IPC President Professor Chris Griffiths says the “WHO 2016 Global Psoriasis Report” supports the need for the Psoriasis Global Atlas project, which the IPC has formed with the International Federation of Psoriasis Associations (IFPA) and the International League of Dermatological Societies (ILDS) to establish a reliable database documenting the burden of the disease worldwide and by country.

IFPA President Lars Ettarp says the report is “an urgent call to action for the international psoriasis community.” Griffiths agrees and says it will reinforce the goals of the global atlas to build an evidence base that can be used to advocate for improved treatment and access to care, collect data and research that could lead to better use of resources, and enable benchmarking within and between countries by collecting consistent and comparable local and regional evidence.

IPC councilors who provided helpful comments, and technical review were Matthias Augustin, Ulrich Mrowietz, Wolf-Henning Boehncke, Mahira Hamdy El Sayed, Peter van de Kerkhof, Mark Lebwohl, Alan Menter, Jörg Prinz, Lone Skov, and Mona Stahle.

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.

now available

COVID-19 Psoriasis Resource Center

Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve

explore now


We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.